MicroRNA isomiRs reveal novel pathways linked to disease activity and fibrosis in MASLD

IsomiRs represent the majority of hepatic miRNAs and uncover novel regulatory networks masked by canonical miRNA analysis. These findings provide new insights into the molecular heterogeneity of MASLD, highlight candidate pathways driving disease progression, and identify potential biomarker and therapeutic targets for precision hepatology.